U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07037823) titled 'Effectiveness of the Combination Strategy of Disease-Modifying Therapy and the Yishen Daluo Yin Modified Formula for Multiple Sclerosis' on June 09.
Brief Summary: This study was designed to investigate the effectiveness of a combined strategy utilizing disease-modifying therapy and the modified Yishen Daluo Yin formula for relapsing-remitting multiple sclerosis (RRMS) through a prospective, multicenter, observational comparative study.
Study Start Date: July 01
Study Type: OBSERVATIONAL
Condition:
RRMS
Intervention:
OTHER: Modified Yishen Daluo Yin formula
The specific application of the modified Yishen Daluo Yin formula, in...